Improving care for patients with diabetic kidney disease during hospital transitions
Official title: Transitions of care program to make guideline-based recommendations actionable for patients with diabetic kidney disease (TOGA-DKD)
Funded at Albert Einstein College of Medicine · NIH-10869841 · Data updated 2026-11-12
This study is looking to help people with diabetic kidney disease by making sure they get the right medications and support when they leave the hospital, especially for those who might need extra help, so they can stay healthier at home.
Quick facts
| Grant type | R03 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Albert Einstein College of Medicine NIH-funded |
| Lab location | 1 site (Bronx, United States) |
| Project start | May 1, 2024 |
| Project end | April 30, 2026 |
| Funding year | 2024 |
| Award (this year) | $100,000 |
| NIH project number | 1R03HS029977-01 |
| Project ID | NIH-10869841 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are patients hospitalized with high-risk diabetic kidney disease who may benefit from enhanced medication management and care coordination.
✕Less likely to help
Patients with diabetic kidney disease who are not hospitalized or those who do not require medication adjustments may not benefit from this research.
What this research studies
This research focuses on enhancing the care of patients with diabetic kidney disease (DKD) during their transition from hospital to home. It aims to identify high-risk patients while they are hospitalized and connect them with a pharmacist-led program that ensures they receive the necessary medications and follow-up care after discharge. By addressing the challenges of medication adherence and care coordination, the program seeks to improve health outcomes for these patients, particularly those from underserved communities. The approach leverages the expertise of pharmacists to facilitate better management of DKD and its complications.
Why it matters
Potential benefit: If successful, this research could significantly improve the health outcomes and quality of life for patients with diabetic kidney disease.
How similar studies have gone: Previous research has shown that pharmacist-led interventions during hospital transitions can improve medication adherence and health outcomes, indicating a promising approach.
Where this research is happening
-
Albert Einstein College of Medicine
Bronx, United States Active
Researchers
- Principal investigator: Di Palo, Katherine E — Albert Einstein College of Medicine
- Study coordinator: Di Palo, Katherine E
Related research
Other NIH-funded projects on the same topics.
-
siRNA nanoparticle treatment to stop diabetic kidney damage
A new nanoparticle-delivered gene-silencing treatment aims to lower kidney inflammation in people with diabetes to help protect their kidneys.
-
LRG1’s role in diabetic kidney disease and kidney fibrosis
A study examines how a specific protein, LRG1, influences kidney disease related to diabetes and its scarring, with the aim of finding targeted ways to slow or prevent damage.
-
Genetic discovery for diabetic kidney disease in adults
A scientist team is studying the genes that influence diabetic kidney disease in adults to better understand why some people develop it.
-
Non-canonical NF-kB and inflammation in diabetic kidney disease
A study to understand how a specific inflammatory pathway worsens kidney disease in adults with type 2 diabetes and how it might be treated.
-
Epidermal microfluidic screen to detect diabetic kidney disease
A new skin-based microfluidic test platform may help identify kidney complications in people with diabetes using real-time biomarkers from sweat and glucose data.
-
PFAS exposure and kidney disease risk in teens with type 2 diabetes
Aging and kidney health study in youths with type 2 diabetes to see how a common chemical (PFAS) affects kidney risk and how to prevent or treat it.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.